Kyprolis (Carfilzomib) Received New Indications as Combination Therapy for Use in Relapsed and/or Refractory Multiple Myeloma (Q37237666)
Jump to navigation
Jump to search
scientific article published on March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Kyprolis (Carfilzomib) Received New Indications as Combination Therapy for Use in Relapsed and/or Refractory Multiple Myeloma |
scientific article published on March 2016 |
Statements
1 reference
Kyprolis (Carfilzomib) Received New Indications as Combination Therapy for Use in Relapsed and/or Refractory Multiple Myeloma (English)
1 reference
Lisa A Raedler
1 reference
1 reference